Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Fischetti

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|October 3, 2009
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiencyFleur Bossi, Fabio Fischetti, Domenico Regoli, et al.
Blood|June 16, 2005
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factorFabio Fischetti, Paolo Durigutto, Valentina Pellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivoAlessandra Polenghi, Fleur Bossi, Fabio Fischetti, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 25, 2020
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological FeaturesClaudio Conforti, Damiano Currado, Roberta Vezzoni, et al.
Arthritis and Rheumatism|February 16, 2012
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5Paolo Macor, Paolo Durigutto, Luca De Maso, et al.
Frontiers in Immunology|September 22, 2017
Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue DamagePaolo Durigutto, Daniele Sblattero, Stefania Biffi, et al.
Journal of Clinical Medicine|May 11, 2024
Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDsMichela Gasparotto, Giuliano Di Pierro, Barbara Toffoli, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification CriteriaFrancesco Bozzao, Paola Tomietto, Elisa Baratella, et al.
Arthritis and Rheumatism|February 2, 2013
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein AGaia Codolo, Fleur Bossi, Paolo Durigutto, et al.
Annals of the Rheumatic Diseases|February 3, 2011
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up studyAmelia Ruffatti, Teresa Del Ross, Manuela Ciprian, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|October 3, 2009
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiencyFleur Bossi, Fabio Fischetti, Domenico Regoli, et al.
Blood|June 16, 2005
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factorFabio Fischetti, Paolo Durigutto, Valentina Pellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivoAlessandra Polenghi, Fleur Bossi, Fabio Fischetti, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 25, 2020
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological FeaturesClaudio Conforti, Damiano Currado, Roberta Vezzoni, et al.
Arthritis and Rheumatism|February 16, 2012
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5Paolo Macor, Paolo Durigutto, Luca De Maso, et al.
Frontiers in Immunology|September 22, 2017
Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue DamagePaolo Durigutto, Daniele Sblattero, Stefania Biffi, et al.
Journal of Clinical Medicine|May 11, 2024
Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDsMichela Gasparotto, Giuliano Di Pierro, Barbara Toffoli, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification CriteriaFrancesco Bozzao, Paola Tomietto, Elisa Baratella, et al.
Arthritis and Rheumatism|February 2, 2013
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein AGaia Codolo, Fleur Bossi, Paolo Durigutto, et al.
Annals of the Rheumatic Diseases|February 3, 2011
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up studyAmelia Ruffatti, Teresa Del Ross, Manuela Ciprian, et al.
Pageof 3